Neurocutaneous Syndromes  >>  Caprelsa (vandetanib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Caprelsa (vandetanib) / Sanofi
NCT00566995: Phase II Study of Vandetanib in Individuals With Kidney Cancer

Checkmark ASCO 2013
May 2013 - May 2013: ASCO 2013
Completed
2
37
US
ZACTIMA (Vandetanib) (ZD6474), Vandetanib
National Cancer Institute (NCI)
Renal Cancer, Von Hippel Lindau
06/14
03/15

Download Options